Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, Kathleen Miley, Stephanie A Irving, Shaun J Grannis, Zachary A Weber, Eric P Griggs, Talia L Spark, Elizabeth Bassett, Peter J Embi, Manjusha Gaglani, Karthik Natarajan, Nimish R Valvi, Toan C Ong, Allison L Naleway, Edward Stenehjem, Nicola P Klein, Ruth Link-Gelles, Malini B DeSilva, Anupam B Kharbanda, Chandni Raiyani, Maura A Beaton, Brian E Dixon, Suchitra Rao, Kristin Dascomb, Palak Patel, Mufaddal Mamawala, Jungmi Han, William F Fadel, Michelle A Barron, Nancy Grisel, Monica Dickerson, I-Chia Liao, Julie Arndorfer, Morgan Najdowski, Kempapura Murthy, Caitlin Ray, Mark W Tenforde, Sarah W Ball
BACKGROUND: Although psychiatric disorders have been associated with reduced immune responses to other vaccines, it remains unknown whether they influence COVID-19 vaccine effectiveness (VE). This study evaluated risk of COVID-19 hospitalization and estimated mRNA VE stratified by psychiatric disorder status. METHODS: In a retrospective cohort analysis of the VISION Network in four US states, the rate of laboratory-confirmed COVID-19-associated hospitalization between December 2021 and August 2022 was compared across psychiatric diagnoses and by monovalent mRNA COVID-19 vaccination status using Cox proportional hazards regression...
March 2024: Influenza and Other Respiratory Viruses